Publications

Evaluating Scope and Bias of Population-Level Measles Serosurveys: A Systematized Review and Bias Assessment.

Sbarra, AN; Cutts, FT; FU, H; Poudyal, I; Rhoda, DA; Mosser, JF; JIT, M;

2024

Vaccines, (2024).12 6 10.3390/vaccines12060585.

Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria.

Williams, SV; Akande, T; ABBAS, K;

2024

PLoS One, (2024).19 3 10.1371/journal.pone.0297326.

Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.

CLARK, RA; Portnoy, A; Weerasuriya, CK; SUMNER, T; Bakker, R; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2024

The Lancet regional health - Southeast Asia (2024). 10.1016/j.lansea.2024.100424.

Social contact patterns following the COVID-19 pandemic: a snapshot of post-pandemic behaviour from the CoMix study.

Jarvis, CI; Coletti, P; Backer, JA; Munday, JD; Faes, C; Beutels, P; Althaus, CL; Low, N; Wallinga, J; Hens, N; EDMUNDS, WJ;

2024

Epidemics, (2024).48, 10.1016/j.epidem.2024.100778.

Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study.

ABBAS, K; Yoo, KJ; Prem, K; JIT, M;

2024

eClinicalMedicine, (2024).70, 10.1016/j.eclinm.2024.102524.

Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use.

Roope, LS J; Morrell, L; Buchanan, J; Ledda, A; Adler, AI; JIT, M; Walker, AS; Pouwels, KB; Robotham, JV; Wordsworth, S; STEPUP team,;

2024

Communications medicine, (2024).4 1 10.1038/s43856-024-00516-9.

Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence.

Matteelli, A; Churchyard, G; Cirillo, D; Den Boon, S; Falzon, D; Hamada, Y; HOUBEN, RM G J; Kanchar, A; Kritski, A; Kumar, B; Miller, C; Menzies, D; Masini, T;

2024

PLOS Global Public Health, (2024).4 7 10.1371/journal.pgph.0003306.

Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.

Hartner, A-M; Li, X; Echeverria-Londono, S; Roth, J; ABBAS, K; AUZENBERGS, M; De Villiers, MJ; Ferrari, MJ; Fraser, K; FU, H; Hallett, T; Hinsley, W; JIT, M; Karachaliou, A; Moore, SM; Nayagam, S; Papadopoulos, T; Perkins, TA; Portnoy, A; Minh, QT; VYNNYCKY, E; Winter, AK; Burrows, H; Chen, C; Clapham, HE; ... Gaythorpe, KA M.

2024

The Lancet Global health, (2024).12 4 10.1016/S2214-109X(23)00603-4.

Estimating epidemiological delay distributions for infectious diseases.

Park, SW; Akhmetzhanov, A; Charniga, K; Cori, A; DAVIES, N; Dushoff, J; FUNK, S; Gostic, K; Grenfell, B; Linton, N; Lipsitch, M; Lison, A; Overton, C; Ward, T; Abbott, S;

2024

medRxiv (2024). 10.1101/2024.01.12.24301247.

Implications of subclinical tuberculosis for vaccine trial design and global effect.

Churchyard, GJ; Houben, RM G J; Fielding, K; Fiore-Gartland, AL; Esmail, H; Grant, AD; Rangaka, MX; Behr, M; Garcia-Basteiro, AL; Wong, EB; Hatherill, M; Mave, V; Dagnew, AF; Schmidt, AC; Hanekom, WA; Cobelens, F; White, RG;

2024

The Lancet. Microbe (2024). 10.1016/s2666-5247(24)00127-7.